Second-Trimester Maternal Serum Levels of Alpha-Fetoprotein and the Subsequent Risk of Sudden Infant Death Syndrome
- 2 September 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (10), 978-986
- https://doi.org/10.1056/nejmoa040963
Abstract
Unexplained stillbirth and the sudden infant death syndrome (SIDS) share some features. A raised maternal serum level of alpha-fetoprotein during the second trimester of pregnancy is a marker of placental dysfunction and a strong predictor of the risk of unexplained stillbirth. It is unknown whether alpha-fetoprotein levels also predict the risk of SIDS.Keywords
This publication has 17 references indexed in Scilit:
- Sudden fetal and infant deaths: Shared characteristics and distinctive featuresSeminars in Perinatology, 2002
- Review of risk factors for Sudden Infant Death SyndromePaediatric and Perinatal Epidemiology, 2001
- Changes in the epidemiology of sudden infant death syndrome in Sweden 1973-1996Archives of Disease in Childhood, 2001
- Sex, birth weight, and the risk of stillbirth in Scotland, 1980-1996.American Journal of Epidemiology, 2000
- The value of a thorough protocol in the investigation of sudden infant deathsJournal of Clinical Pathology, 1998
- Case-control study of sudden infant death syndrome in Scotland, 1992-5BMJ, 1997
- Unexplained stillbirths and sudden infant death syndromeMedical Hypotheses, 1995
- Deprivation and mortality in Scotland, 1981 and 1991BMJ, 1994
- Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of ScotlandJournal of Medical Screening, 1994
- Alpha-FetoproteinEpidemiology, 1993